Drugs News and Research

RSS

Goosby outlines PEPFAR's strategy to strengthen health systems in Reuters interview

U.S. Global AIDS Coordinator Eric Goosby on Tuesday in an interview with Reuters discussed how as part of its new strategy PEPFAR will aim to "to transform healthcare in some of the world's poorest countries," the news agency writes.

7 Jan 2010

Bogus drug manufactures embrace new tactics to dupe consumers

Manufacturers of counterfeit prescription drugs are embracing new tactics to deal with an estimated $75-billion-year market in knockoffs, a battle that is far from being won.

7 Jan 2010

Study explains how H. pylori infection causes stomach cancer

Researchers report that Helicobacter pylori, the only bacterium known to survive in the harsh environment of the human stomach, directly activates an enzyme in host cells that has been associated with several types of cancer, including gastric cancer.

7 Jan 2010

Reuters examines TB in China

Reuters examines efforts to control tuberculosis in China, which has the "world's second largest tuberculosis burden after India." The news service writes, "China has 4.5 million TB cases currently; and each year 1.4 million people fall ill with the disease. TB killed 160,000 people in China in 2008, according to the World Health Organization."

7 Jan 2010

New tools show potential for treating brain disorders

Neuroscientists at MIT have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light.

7 Jan 2010

Tumor Biology Center to initiate Phase 2 clinical trial with CytRx’s INNO-206

CytRx Corporation, a biopharmaceutical company, today announced that the Tumor Biology Center, Freiburg, Germany, plans to initiate a Phase 2 clinical trial with CytRx’s doxorubicin prodrug INNO-206 as a treatment for patients with advanced pancreatic cancer.

6 Jan 2010

Also in global health news: ART access in Zimbabwe; Indonesia bird flu deaths; Kenya floods; Solomon Island tsunami

Zimbabwe's government plans work with international organizations to increase the number of people receiving anti-retroviral therapy (ART) to 300,000 by the end of the year, up from the 180,000 who currently get the drugs, Henry Madzorera, the country's health minister, said on Tuesday, ZimOnline reports.

6 Jan 2010

Ensemble Discovery initiates strategic alliance with Pfizer

Ensemble Discovery today announced the initiation of a strategic alliance with Pfizer Inc. to discover and develop drug candidates of a novel class against a number of high-value pharmaceutical targets.

6 Jan 2010

Medicare beneficiaries can switch their coverage during open enrollment, says Allsup

Medicare annual enrollment ended Dec. 31, but some beneficiaries can switch their coverage during open enrollment from Jan. 1 to March 31, according to Allsup, a nationwide provider of Social Security disability representation and Medicare services.

6 Jan 2010

International Headache Society publishes new guidelines to stimulate more research on headache treatment

If you're one of the millions of headache sufferers around the world, more effective relief might be on the way in years to come. That's because the International Headache Society has just published new research guidelines intended to stimulate more research into headache treatment, and to provide researchers with guidelines to cut health risks associated with treatment.

6 Jan 2010

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Effient(®) (prasugrel) compared with branded clopidogrel (Plavix(®)) was more cost effective, and in most cases cost saving.

6 Jan 2010

Findings open up significant possibilities for developing micro-screening devices for drug discovery

A Nobel-winning process for testing new drugs to treat diseases such as Huntington's, Parkinson's, and muscular dystrophy is getting an electrical charge.

6 Jan 2010

New research shows breast milk is not as important for mother or child's health

Feeling guilty that you didn't breastfeed your children enough - or at all? Relax. New research shows that breast milk is not as important for either the mother or the child's health.

6 Jan 2010

Data from national surveys shows few Americans receive consistent treatment for MDD

Only about half of Americans diagnosed with major depression in a given year receive treatment for it and even fewer - about one-fifth - receive treatment consistent with current practice guidelines, according to data from national surveys supported by the National Institute of Mental Health of the National Institutes of Health.

6 Jan 2010

Historic low in drug spending growth coincides with cost-saving tools developed by PBMs

Expenditures on prescription drugs increased just 3.2 percent in 2008 – the smallest annual rate of increase in 47 years – according to new data released today by the Centers for Medicare and Medicaid Services (CMS).

6 Jan 2010

New survival prediction equation may impact clinical trials for treating PAH

Setting out to determine the survival of patients with pulmonary arterial hypertension (PAH), researchers at the University of Chicago Medical Center and their colleagues also discovered that an equation used for more than 20 years to predict survival is outdated.

6 Jan 2010

Patient enrolled in Phase I clinical study of two investigational compounds: MK-2206 and AZD6244

Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.

6 Jan 2010

Keryx Biopharmaceuticals reaches SPA agreement for Phase 3 clinical program for Zerenex

Keryx Biopharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 clinical program for Zerenex(TM) (ferric citrate), its iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD).

6 Jan 2010

Opinions: U.S. medical emergency response; micronutrients; rotavirus vaccine; antibiotic development

"[D]espite the tireless efforts of public health and health-care workers, America's experience with H1N1 shows that the nation is not prepared to deal with a flu pandemic," former Democratic Senator Bob Graham and former Republican Senator Jim Talent write in Washington Post opinion piece that examines U.S. preparedness for medical emergencies. The writers chaired the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism.

6 Jan 2010

Phase I clinical trial for Intellikine's INK128 inhibitor initiated

Intellikine, Inc. has initiated a Phase I clinical trial for its targeted anticancer drug INK128, a novel orally-available small molecule inhibitor of both the TORC1 and TORC2 complexes, key components of the PI3K/mTOR signaling pathway.

6 Jan 2010

Drugs News and Research

Goosby outlines PEPFAR's strategy to strengthen health systems in Reuters interview

Bogus drug manufactures embrace new tactics to dupe consumers

Study explains how H. pylori infection causes stomach cancer

Reuters examines TB in China

New tools show potential for treating brain disorders

Tumor Biology Center to initiate Phase 2 clinical trial with CytRx’s INNO-206

Also in global health news: ART access in Zimbabwe; Indonesia bird flu deaths; Kenya floods; Solomon Island tsunami

Ensemble Discovery initiates strategic alliance with Pfizer

Medicare beneficiaries can switch their coverage during open enrollment, says Allsup

International Headache Society publishes new guidelines to stimulate more research on headache treatment

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Findings open up significant possibilities for developing micro-screening devices for drug discovery

New research shows breast milk is not as important for mother or child's health

Data from national surveys shows few Americans receive consistent treatment for MDD

Historic low in drug spending growth coincides with cost-saving tools developed by PBMs

New survival prediction equation may impact clinical trials for treating PAH

Patient enrolled in Phase I clinical study of two investigational compounds: MK-2206 and AZD6244

Keryx Biopharmaceuticals reaches SPA agreement for Phase 3 clinical program for Zerenex

Opinions: U.S. medical emergency response; micronutrients; rotavirus vaccine; antibiotic development

Phase I clinical trial for Intellikine's INK128 inhibitor initiated

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News